Skip to main content
Livermore
Livermore
ZHEN

Vantage Consulting Group Inc

SEC CIK
0001843547
Latest filing
Feb 11, 2026

KYNB holding history

Kyntra Bio, Inc. in every 13F filed by Vantage Consulting Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KYNB overviewAll 13F holders of KYNBFull Q4 2025 holdings

Shares (Q2 2025)
0
Sold out in Q2 2025
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of KYNB by Vantage Consulting Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20250$00.0%−7,828−100.0%Sold outConverted for a 1-for-25 splitHolders
Q1 2025195,707$60.6K1.2%00.0%UnchangedHolders
Q4 2024195,707$103.6K1.0%00.0%UnchangedHolders
Q3 2024195,707$78.2K0.7%00.0%UnchangedHolders
Q2 2024195,707$174.6K0.1%00.0%UnchangedHolders
Q1 2024195,707$459.9K0.3%00.0%UnchangedHolders
Q4 2023195,707$173.5K0.1%00.0%UnchangedHolders
Q3 2023195,707$168.9K0.1%00.0%UnchangedHolders
Q2 2023195,707$528.4K0.3%−96,000−32.9%ReducedHolders
Q1 2023291,707$5.44M3.1%−314,006−51.8%ReducedHolders
Q4 2022605,713$9.70M5.7%00.0%UnchangedHolders
Q3 2022605,713$7.88M4.6%00.0%UnchangedHolders
Q2 2022605,713$6.40M3.6%+540+0.1%AddedHolders
Q1 2022605,173$7.28M2.8%−540−0.1%ReducedHolders
Q4 2021605,713$8.54M2.3%00.0%UnchangedHolders
Q3 2021605,713$6.19M1.3%00.0%UnchangedHolders
Q2 2021605,713$16.1M2.8%00.0%UnchangedHolders
Q1 2021605,713$21.0M4.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.